METABOLIC & GLP-1

Tirzepatide

Dual GLP-1 / GIP receptor agonist research peptide.

Dose: 30 mg / vial
Form: Lyophilized powder
Purity: >99% HPLC-verified
Origin: U.S. synthesis

PRICE $ TBD

Synthesized in U.S.A. HPLC-verified PharmaGrade

ABOUT THIS COMPOUND

Tirzepatide 30 MG.

Tirzepatide is a synthetic dual-agonist research peptide that engages both the GLP-1 and GIP receptors. As one of the most-studied dual-pathway compounds in the modern literature, it is a foundational research compound for comparative-agonism investigation.

Each lot is solid-phase synthesized in our U.S. facility from domestically sourced amino acids, HPLC-verified above 99% purity, and lyophilized for research use.

SPECIFICATIONS

Molecule. Method. Documentation.

Compound Data

Molecular weight: ~4,814 Da
Sequence length: 39 amino acids
Form: Lyophilized powder
Purity (HPLC): >99%
Solubility: Reconstitute with bacteriostatic water for research
Storage: Long-term at -20°C; sealed, dark, dry

Storage & Handling

Storage temperature: -20°C long-term
Shelf life (sealed): 24 months
Reconstituted shelf life: 30 days at 2–8°C
Reconstitution: Bacteriostatic water (research use)
Documentation: Lot-specific COA on request

RESEARCH APPLICATIONS

What researchers study.

All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.

Dual GLP-1 / GIP receptor research
Metabolic-pathway pharmacology
Comparative-agonism investigation

QUALITY ASSURANCE

Every vial, the same standard.

U.S. Made Molecule built on American soil

>99% HPLC-verified purity

Lot-Tested COA available on request

PharmaGrade Pharmaceutical-grade synthesis

A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →

YOU MAY ALSO RESEARCH

Related compounds.

VIEW ALL METABOLIC & GLP-1 →

QUESTIONS?

Talk to a human.

Lot questions, COA requests, institutional accounts, reach the team directly.